Exciting New Podcast Series: The Not Just NE Cancer Takeover Series – Advancing Neuroendocrine Cancer Research

Jul 4, 2023

 

We are thrilled to announce the launch of our new podcast series, The Not Just NE Cancer Takeover Series – Advancing Neuroendocrine Cancer Research. This series has been introduced to coincide with our recent campaign, Advancing Research, Funding Answers, which aims to drive progress in neuroendocrine cancer research.

The Not Just NE Cancer Takeover Series is a captivating exploration of all things research related to neuroendocrine cancer. Our host, Lisa will delve into the intriguing world of research, answering fundamental questions such as: What is research? Why is it crucial for advancements in neuroendocrine cancer treatment? And how is it conducted?

In each episode, listeners will have the opportunity to hear insightful interviews with researchers and organisations involved in cutting-edge neuroendocrine cancer research. Our esteemed guests will share their knowledge, experiences, and the latest breakthroughs in the field. Listeners will gain a deeper understanding of the research process and the vital role it plays in improving the lives of those affected by neuroendocrine cancer.

“We are incredibly excited to present The Not Just NE Cancer Takeover Series to our community,” said Catherine Bouvier, CEO of Neuroendocrine Cancer UK. “This podcast series will empower our audience with knowledge about research, and help bridge the gap between researchers and patients. By sharing the remarkable work being done in the field, we hope to inspire and educate listeners.”

Neuroendocrine Cancer UK invites everyone to tune in to The Not Just NE Cancer Takeover Series – Advancing Neuroendocrine Cancer Research. The podcast episodes will be available on our website and major podcast platforms. Stay updated on the latest news by following us on social media and subscribing to our newsletter.

Join us in this exciting journey as we delve into the realm of neuroendocrine cancer research and strive to advance our understanding and treatment of this complex disease.